Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ASRT

Assertio Holdings, Inc.

Healthcare · Pharmaceutical Preparations

$23.50Jun 15, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Assertio Holdings, Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -63% YoY in Q1 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue -63% YoY in Q1 FY2026

Pipeline evidence · 0d ago

ASRT's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ASRT.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q1 2026

Full ASRT earnings analysis

Reported figures for Assertio Holdings, Inc. — research only, not investment advice.

Revenue YoY
-62.5%

Latest Intelligence

Updated

What happened recently for Assertio Holdings, Inc. (ASRT) — events, not interpretation.

Event
Reported Q1 2026 revenue -63% YoY.
Also
Last session June 15, 2026 at $23.5.
Source
Q1 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Assertio Holdings, Inc. (ASRT)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Assertio Holdings, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$151.86M
Revenue:
$9.93M

ASRT earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Assertio Holdings, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.